|
JHP Pharmaceuticals Announces Multi-Year Contract
Manufacturing Agreement
PARSIPPANY, NJ JUNE 29, 2010
JHP Pharmaceuticals, a leading provider of
contract manufacturing services for sterile
injectables, vaccines, ophthalmics and otics
announced today that it has entered into a
multi-year contract supply agreement with an
undisclosed ophthalmic company. Under terms of
the agreement, JHP will be responsible for
manufacturing and supply of a proprietary
ophthalmic product, which is targeted for launch
next year.
Stuart Hinchen co-founder and president of JHP
stated, “We are very pleased that JHP was chosen
for this large-scale multi-year contract. Our
knowledgeable staff, approach to technology
transfer and cGMP compliance record with the
FDA, EMEA and ANVISA allows us to serve this
important customer. We have a long history of
successful partnerships, manufacturing both
commercial products and products in development
with experience taking products from clinical
trial supplies to commercial manufacturing.”
About JHP Pharmaceuticals, LLC
JHP Pharmaceuticals, headquartered in New
Jersey, provides contract manufacturing of
sterile injectable products for large and small
pharmaceutical and biotech organizations.
JHP’s sterile manufacturing facility, located in
Rochester Michigan sits on over 80 acres of land
and includes a 171,000 sq. ft. production
building and 44,000 sq. ft. warehouse. The
production facility utilizes five high-speed
filling lines and seven lyophilizers. The site
also includes separate facilities for chemistry,
sterility testing, and analytical methods
development.
JHP has the capability to manufacture
small-scale clinical or large-scale commercial
products. JHP employs more than 330 staff in the
USA in its manufacturing, sales & marketing and
corporate areas. For more information, please
visit
www.jhppharma.com
Additional Press Releases
|
02/29/12 |
|
JHP Pharmaceuticals Adds Second Product
To Multi-Year Contract Manufacturing Agreement |
 |
|
Webpage
|
PDF Format |
|
|
|
|
07/25/11 |
|
JHP Pharmaceuticals to Produce Clinical Batches of Innovative Cardiac Drug |
|
|
|
Webpage
|
PDF Format |
|
|
|
|
07/06/11 |
|
JHP Pharmaceuticals Enters Agreement To Produce Life-Saving Drug |
|
|
|
Webpage
|
PDF Format |
|
|
|
|
07/05/11 |
|
JHP Pharmaceuticals Launches New Multipack Presentations of Adrenalin®,
Coly-Mycin® M and Pitocin® |
|
|
|
Webpage
|
PDF Format |
|
|
|
|
06/24/11 |
|
JHP Pharmaceuticals Announces Chief
Executive Officer Succession |
|
|
|
Webpage
|
PDF Format |
|
|
|
|
03/28/11 |
|
JHP Pharmaceuticals Announces Multi-Year
Contract Manufacturing Agreement |
|
|
|
Webpage
|
PDF Format |
|
|
|
|
02/24/11 |
|
JHP Pharmaceuticals Enters Another Multi-Year Contract Manufacturing Agreement |
|
|
|
Webpage
|
PDF Format |
|
|
|
|
01/27/11 |
|
JHP Pharmaceuticals & Putney Inc. Announce Multi-Year Contract Manufacturing Agreement |
|
|
|
Webpage
|
PDF Format |
|
|
|
|
06/29/10 |
|
JHP Pharmaceuticals Announces Multi-Year Contract Manufacturing Agreement |
|
|
|
Webpage
|
PDF Format |
|
|
|
|
05/10/10 |
|
JHP Pharmaceuticals Announces Successful
Completion of FDA and EMEA GMP Audits |
|
|
|
Webpage
|
PDF Format |
|
|
|
|
09/28/09 |
|
JHP Announces FDA Approval for Dantrium IV, rapidly mixing in 20 seconds
|
|
|
|
Webpage
|
PDF Format |
|
|
|
|
08/20/08 |
|
JHP Pharmaceuticals & SpePharm complete
purchaseof Dantrium® (dantrolene sodium)
|
|
|
|
Webpage
|
PDF Format |
|
|
|
|
07/16/07 |
|
King Pharmaceuticals Completes Sale Of Rochester, Michigan Manufacturing Facility
To JHP Pharmaceuticals |
|
|
|
Webpage
|
PDF Format |
|
|
|
Return To Press & News
»
|
|
 |
|
